Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Maravai LifeSciences Holdings, Inc. (MRVI) had Receiveable Turnover of 1.85 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$41.63M |
|
$-25.56M |
|
$35.98M |
|
$5.66M |
|
$82.66M |
|
$-41.03M |
|
$-4.12M |
|
$-45.15M |
|
$-45.15M |
|
$-45.06M |
|
$-45.06M |
|
$-45.06M |
|
$-45.06M |
|
$-41.03M |
|
$-25.19M |
|
144.68M |
|
144.68M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$325.87M |
|
$158.62M |
|
$523.32M |
|
$849.19M |
|
$61.57M |
|
$317.79M |
|
$355.76M |
|
$417.33M |
|
$431.86M |
|
$116.55M |
|
$431.86M |
|
255.40M |
|
| Cash Flow Statement Financials | |
$-34.80M |
|
$-29.29M |
|
$-14.68M |
|
$322.40M |
|
$243.57M |
|
$-78.83M |
|
$26.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.29 |
|
-- |
|
-- |
|
0.42 |
|
0.75 |
|
13.58% |
|
-98.56% |
|
-98.56% |
|
-- |
|
-108.45% |
|
-61.39% |
|
$-45.84M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.79 |
|
|
Receiveable Turnover |
1.85 |
48.72 |
|
-10.43% |
|
-38.66% |
|
-5.31% |
|
-6.01% |
|
$1.69 |
|
$-0.32 |
|
$-0.24 |
|